FDA grants fast track status to Aclaris drug for lichen planus
Go back to FDA grants fast track status to Aclaris drug for lichen planus| (NASDAQ: ACRS) | Delayed: 5.72 +0.15 (2.69%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.57 | 52 Week High | $33.88 | |||
| Open | $5.63 | 52 Week Low | $14.12 | |||
| Day High | $5.77 | P/E | N/A | |||
| Day Low | $5.50 | EPS | $0.00 | |||
| Volume | 2,879,401 | |||||
